A study to compare the dose requirement of Oxytocin for management of failure of uterus to contract during caeserean delivery, in patients who received prophylactic Phenylephrine (which is given to manage fall in blood pressure following spinal anaesthesia)
Not Applicable
- Conditions
- Health Condition 1: O746- Other complications of spinal andepidural anesthesia during labor and delivery
- Registration Number
- CTRI/2022/08/044631
- Lead Sponsor
- College of Medicine and Sagore Dutta Hospital Kamarhati Kolkata
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a. single pregnancy at full-term (gestational age �37 weeks)
b. American Society of Anesthesiologists Physical Status I and II
c. aged between 20 and 35 years old undergoing caesarean section
Exclusion Criteria
a. obesity (body mass index, BMI >35 kg/m2),
b. height ( <150 or >170 cm),
c. active labor/ early labor
d. diabetes mellitus or gestational diabetes
e. hypertension or pre-eclampsia
f. intrauterine growth restriction or fetal macrosomia
g. placenta previa, placenta conglutination, placenta implantation
h. significant co-existing maternal disease
i. any absolute contraindications to spinal anesthesia such as local infection or bleeding disorders, and cases with a sensory plane block that did not reach T6 or higher.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. mean total dose of oxytocin used during CD.Timepoint: 24 hours
- Secondary Outcome Measures
Name Time Method 1.proportion (%) of patients requiring a secondary uterotonic agent <br/ ><br>2. estimated blood loss in the 24 h after surgery (EBL) <br/ ><br>3. adverse effects during surgery (hypotension, bradycardia, nausea and vomiting, flushing, chest pain, or dyspnea). <br/ ><br>Timepoint: 24 hours